...
首页> 外文期刊>Cancer letters >Mislocalization of cell-cell adhesion complexes in tamoxifen-resistant breast cancer cells with elevated c-Src tyrosine kinase activity.
【24h】

Mislocalization of cell-cell adhesion complexes in tamoxifen-resistant breast cancer cells with elevated c-Src tyrosine kinase activity.

机译:他莫昔芬抗性乳腺癌细胞中细胞粘附粘附复合物的错位,并具有升高的c-Src酪氨酸激酶活性。

获取原文
获取原文并翻译 | 示例
           

摘要

c-Src activation has been implicated in metastasis of tamoxifen-resistant breast cancer. Here we investigated how c-Src activity affects cell adhesion using a tamoxifen-resistant variant of MCF-7 cells (MTR-3) containing elevated c-Src activity. In MTR-3 cells, adhesion proteins beta-catenin and E-cadherin are mislocalized, forming novel structures perpendicular to cell-cell junctions. c-Src is associated with beta-catenin/E-cadherin complexes and beta-catenin tyrosine phosphorylation is enhanced. Blocking c-Src tyrosine kinase activity decreased beta-catenin tyrosine phosphorylation and restored localization of beta-catenin and E-cadherin at cell-cell junctions. These findings suggest that inhibition of c-Src signaling may prevent metastasis of tamoxifen-resistant breast cancer.
机译:c-Src激活与他莫昔芬耐药性乳腺癌的转移有关。在这里,我们研究了c-Src活性如何使用tamoxifen耐药的MCF-7细胞变体(MTR-3)包含升高的c-Src活性来影响细胞粘附。在MTR-3细胞中,粘附蛋白β-catenin和E-cadherin定位错误,形成垂直于细胞-细胞连接的新结构。 c-Src与β-catenin/ E-cadherin复合物相关,β-catenin酪氨酸磷酸化增强。阻断c-Src酪氨酸激酶活性降低了β-catenin酪氨酸磷酸化并恢复了β-catenin和E-cadherin在细胞间连接处的定位。这些发现表明,抑制c-Src信号传导可预防他莫昔芬耐药性乳腺癌的转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号